PrimateAI-3D outperforms AlphaMissense in real-world cohorts
David A. Parry, Tom Bosc, Tobias Hamp…·Kyle Kai‐How Farh
The paper benchmarks PrimateAI-3D and AlphaMissense on real-world cohorts, finding PrimateAI-3D performs better in rare-disease and biobank settings.